- Home
- DT vs HOLX Comparison
DT vs HOLX Comparison
Compare DT & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DT
- HOLX
- Stock Information
- Founded
- DT 2005
- HOLX 1985
- Country
- DT United States
- HOLX United States
- Employees
- DT N/A
- HOLX N/A
- Industry
- DT Computer Software: Prepackaged Software
- HOLX Medical Electronics
- Sector
- DT Technology
- HOLX Health Care
- Exchange
- DT Nasdaq
- HOLX Nasdaq
- Market Cap
- DT 16.3B
- HOLX 14.5B
- IPO Year
- DT 2019
- HOLX 1990
- Fundamental
- Price
- DT $54.69
- HOLX $65.30
- Analyst Decision
- DT Buy
- HOLX Hold
- Analyst Count
- DT 26
- HOLX 13
- Target Price
- DT $60.71
- HOLX $76.27
- AVG Volume (30 Days)
- DT 2.7M
- HOLX 2.5M
- Earning Date
- DT 08-06-2025
- HOLX 07-28-2025
- Dividend Yield
- DT N/A
- HOLX N/A
- EPS Growth
- DT 205.77
- HOLX 25.36
- EPS
- DT 1.59
- HOLX 2.39
- Revenue
- DT $1,698,683,000.00
- HOLX $4,026,500,000.00
- Revenue This Year
- DT $18.86
- HOLX $2.99
- Revenue Next Year
- DT $14.61
- HOLX $4.91
- P/E Ratio
- DT $34.39
- HOLX $27.24
- Revenue Growth
- DT 18.75
- HOLX 1.66
- 52 Week Low
- DT $39.30
- HOLX $51.90
- 52 Week High
- DT $63.00
- HOLX $84.67
- Technical
- Relative Strength Index (RSI)
- DT 54.51
- HOLX 62.61
- Support Level
- DT $53.69
- HOLX $63.68
- Resistance Level
- DT $55.71
- HOLX $66.65
- Average True Range (ATR)
- DT 1.26
- HOLX 1.27
- MACD
- DT -0.21
- HOLX -0.16
- Stochastic Oscillator
- DT 48.27
- HOLX 48.80
About DT Dynatrace Inc.
Dynatrace is a cloud-native company that focuses on analyzing machine data. Its product portfolio, delivered as software as a service, allows a client to monitor and analyze its entire IT infrastructure. Dynatrace's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to use it for a variety of applications throughout their businesses.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.